Identification of cancer driver genes based on nucleotide context-Reference-Cited by-同舟云学术

Identification of cancer driver genes based on nucleotide context

Published:2020-02 Issue:2 Volume:52 Page:208-218
ISSN:1061-4036
Container-title:Nature Genetics
language:en
Short-container-title:Nat Genet

Author:

Dietlein Felix^ORCID,Weghorn Donate^ORCID,Taylor-Weiner Amaro,Richters André,Reardon Brendan,Liu David,Lander Eric S.^ORCID,Van Allen Eliezer M.^ORCID,Sunyaev Shamil R.^ORCID

Funder

U.S. Department of Health & Human Services | National Institutes of Health

European Molecular Biology Organization

Amazon Web Services

Claudia Adams Barr Program for Innovative Cancer Research ASPIRE Award of The Mark Foundation for Cancer Research

Phillip A. Sharp Innovation in Collaboration Award ASPIRE Award of The Mark Foundation for Cancer Research

Publisher

Springer Science and Business Media LLC

Subject

Genetics

Link

http://www.nature.com/articles/s41588-019-0572-y.pdf

Reference98 articles.

1. Stratton, M. R., Campbell, P. J. & Futreal, P. A. The cancer genome. Nature 458, 719–724 (2009).

2. Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).

3. Stephens, P. J. et al. The landscape of cancer genes and mutational processes in breast cancer. Nature 486, 400–404 (2012).

4. Greaves, M. & Maley, C. C. Clonal evolution in cancer. Nature 481, 306–313 (2012).

5. Bailey, M. H. et al. Comprehensive characterization of cancer driver genes and mutations. Cell 173, 371–385 (2018).

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term longitudinal analysis of 4,187 participants reveals insights into determinants of clonal hematopoiesis;Nature Communications;2024-09-09

2. Allele-specific expression is selected in tumorigenesis, results from epigenetic changes and has prognostic relevance;2024-09-09

3. Worldwide analysis of actionable genomic alterations in lung cancer and targeted pharmacogenomic strategies;Heliyon;2024-09

4. Integrative identification of non-coding regulatory regions driving metastatic prostate cancer;Cell Reports;2024-09

5. IMI-driver: Integrating multi-level gene networks and multi-omics for cancer driver gene identification;PLOS Computational Biology;2024-08-26